Clinical trial Recruiting at 1 site Early Phase 1 Interventional Ages 18 to 70

Ultrasound-Guided Injection for Carpal Tunnel Syndrome: Hyaluronic Acid vs Corticosteroid vs 5% Glucose

Official title: Ultrasound-Guided Injection of Mild to Moderate Carpal Tunnel Syndrome Using Hyaluronic Acid vs Corticosteroid vs 5% Glucose: Comparative Study

Run by Tanta University · NCT07825155 · Data updated 2026-11-12

This study tests three ultrasound-guided injections (hyaluronic acid, corticosteroid, and 5% glucose) to see which best helps adults with mild to moderate carpal tunnel syndrome.

More Carpal Tunnel Syndrome (CTS) trials

Quick facts

PhaseEarly Phase 1
Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment60 (estimated)
SponsorTanta University
Academic / other
Locations1 site (Tanta, Gharbia Governorate)
StatusRecruiting
StartedMarch 15, 2026
Main results expectedJune 20, 2026
Study endsOctober 30, 2026
Registry record updatedSeptember 23, 2026
Trial IDNCT07825155 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18-70 with six or more weeks of CTS symptoms and confirmed mild to moderate CTS by clinical and electrophysiological criteria.

Probably not a fit

Patients with severe CTS, prior wrist injections within six months, prior carpal tunnel surgery, local infection, or coagulation issues may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This early-phase, randomized comparison will enroll 60 adults with clinically and electrophysiologically confirmed mild to moderate CTS and assign 20 to each injection type. Each participant will receive a single ultrasound-guided injection of either hyaluronic acid, corticosteroid, or 5% glucose and will be evaluated after three months. Assessments will include clinical signs (Phalen's test, Tinel's sign), nerve conduction studies, and ultrasound measurement of the median nerve cross-sectional area. The trial aims to determine relative effectiveness and safety of these injectates in improving symptoms and nerve function. Results will inform whether alternative injections could offer benefits over standard corticosteroid therapy for CTS.

Why it matters

Potential benefit: If successful, patients could have longer-lasting symptom relief or improved nerve function with a potentially safer or more effective injectable option.

How similar studies have gone: Previous studies have shown promising results for hyaluronic acid and hydrodissection with glucose in CTS, but head-to-head comparisons with corticosteroids are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Adults aged 18-70 years. Clinical symptoms of carpal tunnel syndrome for ≥6 weeks. Electrophysiological confirmation of mild to moderate carpal tunnel syndrome. Ability to provide informed consent.

\-

Exclusion Criteria:

* Prior injection into the same wrist within the previous 6 months. Previous carpal tunnel surgery. Severe carpal tunnel syndrome, defined by absent sensory potentials or electromyographic evidence of denervation.

Local infection or coagulopathy.

Where it's running

  • Tanta University Faculty of Medicine
    Tanta, Gharbia Governorate, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.